Project Grant R43DK137607

Award Date 9/12/24
Completion Date 8/31/26
Dollars Obligated $425K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
The Johns Hopkins University received a $806,274 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to develop and evaluate "Interactive Sensory Insoles" - a novel foot overload warning device designed to monitor gait parameters and provide real-time pressure offloading cues to patients with diabetes to help prevent recurrent diabetic foot ulcers. The award period runs from September 10, 2025 to June 30, 2030. The project aims to...
This $205,000 project grant from the National Institutes of Health's National Institute on Aging will fund research into the pathomechanics of diabetic foot ulcers at The University of Texas Southwestern Medical Center over a 12-month period. The research aims to identify more accurate markers and marker combinations for foot ulceration risk in patients with diabetic neuropathy and a history of prior ulcers. Using specialized equipment, the study will quantify two primary ulcer-causing...
This SBIR Phase I project, funded by the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop an innovative implantable device for treating diabetic foot ulcers (DFUs). The $295,000 grant awarded to Biodynamik, a for-profit small business, will support the design and feasibility testing of a low-profile transverse tibial transport (TTT) implant. This implant leverages the principles of distraction osteogenesis to stimulate soft...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,000,000 to Empo Health, Inc. supports the productization, clinical validation, and quality & regulatory activities for an in-home diabetic foot imaging bathroom scale system. The project aims to develop a novel remote health monitoring product to help reduce severe diabetic foot ulcers, which affect approximately one-quarter of diabetic patients and can lead to...
The University of California, San Diego received a $1,187,347 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to develop photoacoustic ultrasound imaging tools that can predict and monitor the response of diabetic foot ulcers (DFUs) to therapy. The goal is to quickly identify at-risk tissue and prevent DFU relapse, which account for approximately one-third of the total cost of diabetic care. Over the 2-year award period from September...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $687,416 Project Grant under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research) to Lynntech Inc., a small business technology development company based in College Station, Texas. The grant will support the development of a cutaneous gel to deliver a therapeutic with an intriguing mechanism of action to effectively treat diabetic foot ulcers (DFUs). The project aims to: (1) prepare,...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Therapeutic Bandage Products, Inc. will develop an advanced wound care product to speed healing of diabetic foot ulcers. The patented microneedle patch design will deliver three therapeutic agents to the wound site - an antibiotic to kill bacteria, an agent to prevent biofilm reformation, and a chemokine to activate white blood cells for cleanup. This product aims to...
The University of North Texas Health Science Center at Fort Worth received a $268,377 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) on February 25, 2025. The grant aims to develop and evaluate a novel device using high-frequency, low-amplitude vibration (HFLAV) for accelerating the healing of Stage 2 diabetic foot ulcers (DFUs). Key objectives include enhancing the driver device, validating its safety, and conducting a small clinical...
The federal Project Grant award of $555,034.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, titled "Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-FOOT-NAV), A Randomized Controlled Trial", aims to assess the effectiveness of a comprehensive navigator program in improving care and healing for...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $1,024,812 Project Grant to Epoulosis Therapeutics Inc. located in Newton, MA. The grant, awarded on August 1, 2025, aims to develop novel treatments for diabetic foot ulceration (DFU) in the form of a wound bandage employing new biomaterials that can release appropriate doses of the drug metrifonate. This is based...

SMART FOOT MAT - SMART FOOT MAT ABSTRACT EDEN MEDICAL IS PLEASED TO DEVELOP THE SMART FOOT MAT (SFM), AS A SIMPLE IN-HOME APPLIANCE FOR STOPPING DIABETIC FOOT COMPLICATIONS. WE PROPOSE A POWERFUL GAME-CHANGING STRATEGY HAVING DIABETICS STEP ON THEIR SMART MAT AT HOME ONCE A DAY TO MONITOR THEIR FOOT OXIMETRY AND TEMPERATURE OVER TIME TO ALERT THEM EARLY SIGNS OF ULCER ONSET. NEAR INFRARED SPECTROSCOPY (NIRS) BIOMARKERS PROVIDE A QUANTITATIVE ULCER RISK METRIC AND CAN USED TO PREDICT DIABETIC FOOT ONSET. COMPLICATIONS OF DIABETES THAT AFFECT THE LOWER EXTREMITIES ARE COMMON, COMPLEX, AND COSTLY. DIABETES IS THE MOST COMMON METABOLIC DISEASE WORLDWIDE WITH GLOBAL COST OF DIABETES MANAGEMENT INCLUDING FOOT ULCERATION IS NOW $825 BILLION DOLLARS EVERY YEAR. FOOT ULCERATION IS THE MOST FREQUENTLY RECOGNIZED COMPLICATION WITH 537 MILLION ADULTS WHO LIVE WITH DIABETES GLOBALLY AND IT PREDICTED TO RISE TO 643 MILLION BY 2030. RECENT INVESTIGATIONS SUGGEST THAT 40% OF PATIENTS EXPERIENCE A RECURRENT DIABETIC FOOT ULCER (DFU) IN THE YEAR AFTER HEALING, AND ALMOST 60% WITHIN 3 YEARS. DAILY IN-HOME MONITORING WILL PROVIDE ULCER-FREE LIVING FOR HIGH-RISK DIABETIC PATIENTS.

Posted 9/10/24